Skip to main content
Clinical Trials/ACTRN12613001114730
ACTRN12613001114730
Completed
N/A

A study on the effects of noninvasive ventilation used as weaning strategy on duration of invasive mechanical ventilation when compared to a conventional weaning approach with endotracheal tube in place in patients with hypoxemic acute respiratory failure.

avalesi Paolo0 sites130 target enrollmentOctober 4, 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Weaning in Hypoxemic Acute Respiratory Failure
Sponsor
avalesi Paolo
Enrollment
130
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 4, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
avalesi Paolo

Eligibility Criteria

Inclusion Criteria

  • Invasive mechanical ventilation duration \> 48 hours; PaO2/FiO2 ranging between 200 and 300 with a positive end\-expiratory pressure PEEP \> 8 and \< \= 12 cmH2O and a FiO2 \<\= 0\.6; Pressure Support Ventilation (PSV) with a total applied pressure (i.e. PEEP \+ inspiratory support) \<\= 25 cmH2O; PaCO2 \<\= 50 mmHg; pH \>\= 7\.35; Respiratory rate (RR) \<\= 30/min; Core body temperature \<\= 38\.5 (degrees celsius); Glasgow Coma Scale (GCS) \>\= 10; Presence of clearly audible cough during suctioning; Tracheal suctioning\<\= 2/hr

Exclusion Criteria

  • Severe hemodynamic instability as assessed: a) systolic arterial pressure \< 90 mmHg, despite adequate filling, b) need for continuous infusion of epinephrine, norepinephrine or vasopressine, c) need for dopamine or dobutamine \> 5microg/Kg/min
  • Life\-threatening arrhythmias or ECG signs of ischemia; Severe sepsis or septic shock;
  • ARF secondary to congestive heart failure, neurological disorders, status asmaticus, chronic obstructive pulmonary disease; Tracheotomy; Copious secretions or uncontrolled vomiting; Spinal cord injury or neuro\-muscular disorder; Presence of 2 or more criteria of organ failure; Body mass index \>\= 30; Obstructive sleep apnea syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials